期刊文献+

乳腺癌患者术中分子诊断的应用意义分析与研究

Significance Analysis and Research of Breast Cancer Patients in the Application of Molecular Diagnostic
下载PDF
导出
摘要 目的研究乳腺癌患者术中分子诊断的应用意义。方法我院乳腺病中心2013年1月至2015年8月收治乳腺癌患者共66例,前哨淋巴结(SLN)活检标本122枚,采用Genesearch法进行检测,与冰冻和石蜡组织学结果作对照,分析SLN诊断中Genesearch检测的应用意义。结果本组宏转移16枚,微转移2枚,无肿瘤转移104枚。GeneSearch检测阳性18枚,阴性104枚,检测灵敏度、特异度、阳性预测值、阴性预测值、符合率为88.9%、96.2%、80.0%、98.0%、95.1%。结论 Genesearch检测的灵敏度、特异度较高,可作为SLN术中诊断的重要方法。 Objective To study the application of molecular diagnosis in breast cancer patients. Methods Our hospital mammary gland disease center in January 2013 to August 2015 were a total of 66 patients with breast cancer, 122, sentinel lymph nodes (SLNS) detected biopsy specimens Genesearch method is used for testing, and frozen and paraffin histologic results contrast, analysis of SLNS diagnosis of detected Genesearch test application significance. Results 16 macro transfer, the transfer of two, no tumor metastasis 104. GeneSearch test positive for 18, negative 104, detection sensitivity, specific, positive predictive value, negative predictive value, coincidence rate was 88.9%, 88.9%, 80.0%, 98.0%, 95.1%. Conclusion The Genesearch detection sensitivity, specific degree is higher, can be used as important methods for the diagnosis of SLNS intraoperative detected.
作者 赵诤 张美华 ZHAO Zheng;ZHANG Mei-hua(Department of Clinical Laboratory,Guangyuan Central Hospital,Guangyuan 628000,China)
出处 《中国医药指南》 2019年第12期39-40,共2页 Guide of China Medicine
关键词 乳腺癌 分子诊断 应用 前哨淋巴结 Breast cancer Molecular diagnosis Application Sentinel lymph node
  • 相关文献

参考文献4

二级参考文献49

  • 1Turner RR,Ollila DW,Stern S,et al.Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging.Am J Surg Pathol,1999,23(3):263-267.
  • 2Schrenk P,Rieger R,Shamiyeh A,et al.Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma.Cancer,2000,88 (3):608-614.
  • 3Kim T,Giuliano AE,Lyman GH.Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma:a metaanalysis.Cancer,2006,106(1):4-16.
  • 4Ferrari A,Rovera F,Dionigi P,et al.Sentinel lymph node biopsy as the new standard of care in the surgical treatment for breast cancer.Expert Rev Anticancer Ther,2006,6(10):1503-1515.
  • 5Wilson LL,Giuliano AE.Sentinel lymph node mapping for primary breast cancer.Curr Oncol Rep,2005,7(1):12-17.
  • 6Posther KE,Wilke LG,Giuliano AE.Sentinel lymph node dissection and the current status of American trials on breast lymphatic mapping.Semin Oncol,2004,31(3):426-436.
  • 7Cserni G,Amendoeira I,Apostolikas N,et al.Pathological workup of sentinel lymph nodes in breast cancer.Review of current data to be considered for the formulation of guidelines.Eur J Cancer,2003,39(12):1654-1667.
  • 8American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.J Clin Oncol,2005,23(30):7703-7720.
  • 9Cserni G,Bianchi S,Vezzosi V,et al.Variations in sentinel node isolated tumour cells/micrometastasis and non-sentinel node involvement rates according to different interpretations of the TNM definitions.Eur J Cancer,2008,44 (15):2185-2191.
  • 10Reed J,Rosman M,Verbanac KM,et al.Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer:10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multicenter Study.J Am Coll Surg,2009,208(3):333-340.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部